Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 2
2012 2
2019 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
van Roon AH, Hol L, van Vuuren AJ, Francke J, Ouwendijk M, Heijens A, Nagtzaam N, Reijerink JC, van der Togt AC, van Ballegooijen M, Kuipers EJ, van Leerdam ME. van Roon AH, et al. Among authors: heijens a. Am J Gastroenterol. 2012 Jan;107(1):99-107. doi: 10.1038/ajg.2011.396. Epub 2011 Nov 22. Am J Gastroenterol. 2012. PMID: 22108450
MALDI-Mass Spectrometry Imaging to Investigate Lipid and Bile Acid Modifications Caused by Lentil Extract Used as a Potential Hypocholesterolemic Treatment.
Genangeli M, Heijens AMM, Rustichelli A, Schuit ND, Micioni Di Bonaventura MV, Cifani C, Vittori S, Siegel TP, Heeren RMA. Genangeli M, et al. Among authors: heijens amm. J Am Soc Mass Spectrom. 2019 Oct;30(10):2041-2050. doi: 10.1007/s13361-019-02265-9. Epub 2019 Aug 5. J Am Soc Mass Spectrom. 2019. PMID: 31385259 Free PMC article.
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.
Rijckborst V, ter Borg MJ, Cakaloglu Y, Ferenci P, Tabak F, Akdogan M, Simon K, Raptopoulou-Gigi M, Ormeci N, Zondervan PE, Verhey E, van Vuuren AJ, Hansen BE, Janssen HL; PARC Study Group. Rijckborst V, et al. Am J Gastroenterol. 2010 Aug;105(8):1762-9. doi: 10.1038/ajg.2010.186. Epub 2010 May 11. Am J Gastroenterol. 2010. PMID: 20461068 Clinical Trial.
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.
Rijckborst V, Ferenci P, Akdogan M, Pinarbasi B, ter Borg MJ, Simon K, Flisiak R, Akarca US, Raptopoulou-Gigi M, Verhey E, van Vuuren AJ, Boucher CA, Hansen BE, Janssen HL; PARC Study Group. Rijckborst V, et al. Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1012-9. doi: 10.1097/MEG.0b013e3283557e23. Eur J Gastroenterol Hepatol. 2012. PMID: 22668876 Clinical Trial.